✦ LIBER ✦

Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells

✍ Scribed by Steffen Klippel; Jana Jakubikova; Jake Delmore; Melissa Ooi; Douglas McMillin; Efstathios Kastritis; Jacob Laubach; Paul G. Richardson; Kenneth C. Anderson; Constantine S. Mitsiades

Book ID: 117946833
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 585 KB
Volume: 159
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09253.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activity of fludarabine agains

Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo

✍ Haitao Meng; Chunmei Yang; Wanmao Ni; Wei Ding; Xiudi Yang; Wenbin Qian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Thymoglobulin targets multiple plasma ce

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma

✍ Timm, M M; Kimlinger, T K; Haug, J L; Kline, M P; Greipp, P R; Rajkumar, S V; Ku 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 269 KB

In vitro activity of dimethylarsinic aci

In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines

✍ Hatice Duzkale; Iman Jilani; Nada Orsolic; Ralph A. Zingaro; Mirna Golemovic; Fr 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 299 KB

Selective targeting of immunoliposomal d

Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo

✍ Daniel E. Lopes de Menezes; Linda M. Pilarski; Andrew R. Belch; Theresa M. Allen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Liposomal daunorubicin: in vitro and in

Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma

✍ G. Pratt; M. E. Wiles; A. C. Rawstron; F. E. Davies; J. A. L. Fenton; J. A. Prof 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

Liposomal encapsulation of anthracyclines is a potential method of drug targeting, altering both the antitumour activity and side-effect profile of anthracyclines. Liposomal daunorubicin (daunoxome) shows both altered pharmacokinetics and a potential for reducing dose-limiting cardiotoxicity compare

Sialyltransferase activity in plasma cel

Sialyltransferase activity in plasma cells of multiple myeloma

✍ A. M. Cohen; D. Allalouf; M. Djaldetti; K. Weigl; N. Lehrer; H. Levinsky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB